Immix Biopharma
Price & Volume
Stats
See more52W Range | $1.34-$4.60 |
Market Cap | $144.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.77 |
News
See moreYahoo Finance • 17 days ago
Immix Biopharma appoints Michael Grabow as chief commercial officer to drive NXC-201 launch
Yahoo Finance • 17 days ago
Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch
Yahoo Finance • 26 days ago
Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025
Yahoo Finance • 2 months ago
Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
About
CEO | Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D. |
CFO | Mr. Gabriel Morris B.A. |
Address | 11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 18 |
